Pharma's broken business model - Part 2: Scraping the barrel in drug discovery

Part 2 of Kelvin Stott’s great work on pharma declining R&D ROI. Why aren’t we finding and drugging new therapeutic targets more efficiently?
Read More

Pharma's broken business model - Part 1: An industry on the brink of terminal decline

Part one of a very insightful analysis by Kelvin Stott showing Pharmaceutical IRR will hit 0% by 2020. Why isn’t translational success rising given better research methodologies and richer datasets?
Read More